Preferred Pharmaceuticals Recalls Losartan Potassium Tablets Due to Impurity
Preferred Pharmaceuticals is recalling Losartan Potassium 50 mg tablets because an impurity, N-Methylnitrosobutyric acid (NMBA), was identified.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the presence of a nitrosamine impurity (NMBA) in a prescription drug represents a significant health risk, aligning with the 'Severe' criteria for significant injury reports or high-risk contamination.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Losartan Potassium Tablets, USP, 50 mg. The affected products are 30-count and 90-count bottles manufactured by Torrent Pharma Inc. and relabeled by Preferred Pharmaceuticals, Inc. The recall involves 530 units distributed in California, Georgia, and Indiana.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the presence of an impurity, N-Methylnitrosobutyric acid (NMBA), was identified in the product. The affected lots include 30-count bottles with lot codes C2218C (exp 9/2020) and D1318E (exp 10/2020), and 90-count bottles with lot codes C2719J (exp 9/2020) and E1818B (exp 10/2020).
Consumers who have these specific lot numbers should stop using the medication and contact their healthcare provider for guidance on alternative treatment options. The products are prescription-only (Rx Only).
The recalled product
- Product
- Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Torrent Pharma Inc. Basking Ridge, NJ. Relabeled by: Preferred Pharmaceuticals, Inc. 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807.
- Manufacturer
- Preferred Pharmaceuticals, Inc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 530
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Count
- lots
- expiry: a) 30-count bottle C2218C
- exp 9/2020
- D1318E
- exp 10/2020
- b) 90-count bottle C2719J
- E1818B
- exp 10/2020.
Distribution
Related recalls
Same manufacturer · Preferred Pharmaceuticals, Inc
See all →- HighGeri-Care artificial tears lubricant eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- ModerateOndansetron blister packs recalled because tablets are falling out
FDA (Drugs) · 2025-12-24
- ModerateClindamycin Hydrochloride Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-07
- HighIbuprofen Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-09-04
- HighDuloxetine Delayed-Release Capsules Recalled for Nitrosamine Impurity
FDA (Drugs) · 2024-05-29
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17